Nuedexta gets a positive recommendation from the European Medicines Agency for the treatment of Pseudobulbar effect in patients living in Europe. The article can be found here.
Dr. Smith quoted in recent article in the Alzheimer's Research Forum about using stem cell-based screening method to model ALS.